Innovative Medicines Initiative (IMI) Calls 11 and 12 Open


Call 11 focuses in particular on the following IMI projects: EMTRAIN and PharmaTrain (both education and training), EUPATI (patient education), Open PHACTS (data management), RAPP-ID (infectious disease diagnostics), WEB-RADR (reporting of medicines side effects), and GetReal (incorporation of real world data into drug development). Call 12 Development and validation of technology enabled, quantitative and sensitive measures of functional decline in people with early stage Alzheimer’s disease (RADAR-AD) FAIRification of IMI and EFPIA data Development of sensitive and validated clinical endpoints in primary Sjögren’s Syndrome (pSS) European health data network (EHDN) Analysing the infectious disease burden and the use of vaccines to improve healthy years in aging populations Discovery and characterisation of blood-brain barrier targets and transport mechanisms for brain delivery of therapeutics to treat neurodegenerative & metabolic diseases European Screening Centre: unique library for attractive biology (ESCulab) Deadline for submitting proposals (both Calls): 24 October 2017. Information